Search - tctmd.com

Displaying 1 - 20 of 161

Sort: Relevancy | Date

News Conference News TCT 2025

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

Yael L. Maxwell

November 07, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

August 01, 2025

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

June 12, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

Presentation TCT 2024

Evolution of PCI – Role and Value of Drug-Eluting Balloons

Presenter: Roxana Mehran

October 29, 2024

Presentation TCT 2024

LIMUS as the Drug of Choice for Drug-Eluting Balloons

Presenter: Aloke Finn

October 29, 2024

Presentation TCT 2024

TCT 449: Long Term Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease

Presenter: Hesham Refaat

October 28, 2024

Presentation TCT 2024

TCT 445: Three-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small Coronary Arteries: A Systematic Review and Meta-Analysis

Presenter: Jeremy Levett

October 28, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News ESC 2024

REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD

Todd Neale

September 09, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

News Industry News

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

June 18, 2024

News Daily News

DCB in STEMI Match DES Through 5 Years: REVELATION

Caitlin E. Cox

March 27, 2024

News Conference News CRT 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

L.A. McKeown

March 14, 2024

News Daily News

UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI

L.A. McKeown

February 06, 2024

News Conference News TCT 2023

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Todd Neale

November 02, 2023

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

Presentation TCT 2023

TCT 811: Drug Eluting Balloon for Early Aggressive Neointimal Hyperplasia for Coronary Artery In-Stent Restenosis

Presenter: Parth Parikh

October 24, 2023

Advertisement

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

What’s Going to Be Hot at TCT 2025

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

Top Coronary Artery Disease News in 2024

Evolution of PCI – Role and Value of Drug-Eluting Balloons

LIMUS as the Drug of Choice for Drug-Eluting Balloons

TCT 449: Long Term Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease

TCT 445: Three-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small Coronary Arteries: A Systematic Review and Meta-Analysis

What’s Going to Be Big at TCT 2024?

REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD

DES Best for In-Stent Restenosis, but DCBs Also Viable

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

DCB in STEMI Match DES Through 5 Years: REVELATION

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Comparing DCBs in De Novo CAD: Drugs, Design Matter

TCT 811: Drug Eluting Balloon for Early Aggressive Neointimal Hyperplasia for Coronary Artery In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content